Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quo vadis, BGA? A collaborative EDNAP exercise on the challenges and progress in forensic biogeographical ancestry inference.

Forensic science international. Genetics·2026
Same author

Pharmacokinetics and dosimetry of radiolabeled FAP-targeting single-domain antibody 4AH29 in Göttingen minipigs.

Nuclear medicine and biology·2026
Same author

Bilateral Giant Pigment Epithelial Detachments and Unilateral RPE Tear and Exudative Retinal Detachment After Tadalafil Exposure: Case Report and Review of the Literature.

Retinal cases & brief reports·2026
Same author

Characterizing the Fate of Anti-CS1 Nanobody Displaying Extracellular Vesicles in Multiple Myeloma.

Journal of extracellular vesicles·2026
Same author

Automated and manual synthesis of [<sup>68</sup>Ga]Ga-DOTA-4AH29 intended for PET-imaging of FAP-expression.

EJNMMI radiopharmacy and chemistry·2026
Same author

Advancing forensic SNP typing: Insights from an interlaboratory study of the FORCE panel.

Forensic science international. Genetics·2026

Related Experiment Video

Updated: May 19, 2026

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

Molecular imaging using Nanobodies: a case study.

Nick Devoogdt1, Catarina Xavier, Sophie Hernot

  • 1In Vivo Cellular and Molecular Imaging (ICMI) Laboratory, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Methods in Molecular Biology (Clifton, N.J.)
|August 14, 2012
PubMed
Summary

Nanobodies offer a novel solution for molecular imaging probes, providing high-contrast images with rapid clearance. This platform may enable the next generation of targeted molecular imaging agents.

More Related Videos

Live-cell Imaging of Endocytic Transport using Functionalized Nanobodies in Cultured Cells
08:02

Live-cell Imaging of Endocytic Transport using Functionalized Nanobodies in Cultured Cells

Published on: October 17, 2025

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells
11:05

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells

Published on: February 21, 2019

Related Experiment Videos

Last Updated: May 19, 2026

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

Live-cell Imaging of Endocytic Transport using Functionalized Nanobodies in Cultured Cells
08:02

Live-cell Imaging of Endocytic Transport using Functionalized Nanobodies in Cultured Cells

Published on: October 17, 2025

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells
11:05

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells

Published on: February 21, 2019

Area of Science:

  • Biotechnology
  • Medical Imaging
  • Pharmacology

Background:

  • Molecular imaging enables noninvasive measurement of biological processes.
  • Advances in imaging hardware and software necessitate new targeted molecular probes.
  • Nanobodies possess unique properties suitable for molecular imaging tracers.

Purpose of the Study:

  • To evaluate Nanobodies as a platform for developing next-generation molecular imaging probes.
  • To assess the in vivo targeting capabilities and pharmacokinetic properties of Nanobody-based probes.

Main Methods:

  • Utilized Nanobodies, leveraging their physicochemical and pharmacokinetic characteristics.
  • Conducted preclinical studies to assess in vivo targeting and biodistribution.
  • Administered probes intravenously and evaluated image contrast at early time points.

Main Results:

  • Demonstrated strong and specific in vivo targeting with Nanobody-based probes.
  • Observed rapid clearance of unbound Nanobody probes from circulation.
  • Achieved high-contrast molecular imaging at early time points post-administration.

Conclusions:

  • Nanobodies exhibit ideal properties for molecular imaging tracers.
  • The Nanobody platform shows significant potential for developing next-generation molecular imaging probes.
  • This approach may offer a generic method for creating advanced molecular imaging agents.